Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000 Apr;231(4):471-9.
doi: 10.1097/00000658-200004000-00004.

Ex vivo and in situ resection of inferior vena cava with hepatectomy for colorectal metastases

Affiliations

Ex vivo and in situ resection of inferior vena cava with hepatectomy for colorectal metastases

J P Lodge et al. Ann Surg. 2000 Apr.

Abstract

Objective: To describe the surgical techniques and early results of inferior vena cava (IVC) resection in patients with advanced liver tumors.

Summary background data: Involvement of the IVC by hepatic tumors, although rare, is considered inoperable by standard resection techniques. Concomitant hepatic and IVC resection is required to achieve adequate tumor clearance.

Methods: Between February 1995 and February 1999, 158 patients underwent hepatic resection for colorectal metastases in the authors' unit. Eight patients, aged 42 to 80 years (mean 62 years), with hepatic metastases from colorectal cancer underwent concomitant resection of the IVC and four to six hepatic segments. Resections were carried out under total hepatic vascular exclusion in four patients and ex vivo in four patients. Between 30 degrees and 360 degrees of the retrohepatic IVC was resected and replaced with an autogenous vein patch (n = 1), a ringed Gore-Tex tube graft (n = 2), a Dacron tube graft (n = 1), or a patch (n = 3) or was repaired by primary suturing (n = 1).

Results: There were two early deaths from multiple organ failure. One patient survived 30 months after ex vivo resection but died of renal cell carcinoma, and another died with recurrent disease at 9 months. The remaining four patients remained alive 5 to 12 months after surgery, with no hepatic failure or venous obstruction; tumor recurrence was present in two. Nonthrombotic occlusion of the neocava occurred in one patient and was stented successfully.

Conclusions: Although concomitant hepatic and IVC resection is associated with a considerable surgical risk, this aggressive surgical approach offers hope for patients with hepatic tumors involving the IVC, who would otherwise have a dismal prognosis. This procedure can be performed under total hepatic vascular exclusion, with or without venovenous bypass, and by ex vivo bench resection.

PubMed Disclaimer

Figures

None
Figure 1. Preoperative CT scan (patient 7) demonstrated a large colorectal metastatic tumor that destroyed the right portal structures, abutted the left portal triad structures, and was in close apposition to the inferior vena cava.
None
Figure 2. (A) The line of this ex vivo hepatic resection (patient 7) was to the left of the falciform ligament. Parts of segments 2 and 3 were removed en bloc with segments 1 and 4 through 8. Part of the left hepatic vein has been resected, and the left portal vein and hepatic artery have been divided at the division of segments 2 and 3. (B) The resected inferior vena cava was replaced with a 20-mm ringed polytetrafluoroethylene graft that was anastomosed to the left hepatic vein remnant before implantation.
None
Figure 3. Vascular isolation techniques. This diagram demonstrates the placement of vascular clamps and the extent of inferior vena cava resection (shaded area) in each case. Portosystemic venovenous bypass was used during ex vivo resections (patients 1, 2, 7, and 8). Total hepatic vascular isolation was used in patients 4 and 5. IVC, inferior vena cava; RHV, right hepatic vein; LHV, left hepatic vein; AV, adrenal vein; RV, renal vein; PV, portal vein; CHA, common hepatic artery.

References

    1. Bengtsson G, Carlsson G, Hafstrom L, Jonsson P. Natural history of patients with untreated liver metastases from colorectal cancer. Am J Surg 1981; 141:586–589. - PubMed
    1. Lahr CJ, Soong S-J, Cloud G, et al. A multifactorial analysis of prognostic factors in patients with liver metastases from colorectal carcinoma. J Clin Oncol 1983; 1:720–726. - PubMed
    1. Rougier P, Milan C, Lazoethes F, et al. Prospective study of prognostic factors in patients with unresected hepatic metastases from colorectal cancer. Br J Surg 1995; 82:1397–1400. - PubMed
    1. Wagner JS, Adson MA, van Heerden JA, et al. The natural history of hepatic metastases from colorectal cancer: a comparison with resective treatment. Ann Surg 1984; 199:502–508. - PMC - PubMed
    1. Isenberg J, Fischbach R, Kruger I, Keller HW. Treatment of liver metastases from colorectal cancer. Anticancer Res 1996; 16:1291–1295. - PubMed